Gelonghui April 28 丨 Changshan Pharmaceutical (300255dk7comslot.SZ) released its 2023 annual report. During the reporting period, the company's operating income was 1.41 billion yuan, a year-on-year decrease of 39.63%. attributable to shareholders of listed companiesdk7comslotThe net loss was 1.24 billion yuan. The net loss attributable to shareholders of listed companies after deducting non-recurring gains and losses was 1.258 billion yuan. The basic loss per share was 1.35 yuan.